Abbott has warned healthcare providers about a new issue with the mobile power units of certain HeartMate 3 LVADs. 

"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.

The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.

Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy. 

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification. 

New Hampshire-based Conformal Medical plans on using the funds to enroll more patients into an ongoing clinical trial. 

New HFSA recommendations highlight the importance of integrating palliative care into the day-to-day care of heart failure patients.

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new research published in the Journal of the American Heart Association. It does not, however, improve survival.

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society shared a detailed analysis of the situation.

Researchers say their findings suggest that medications that increase prefrontal dopamine "are an important lead to pursue.” 

A 58-year-old man in Texas is suing Baylor University Medical Center and a surgical team after a retractor was left inside his body, leaving him in severe pain for days after a tumor extraction.